An in-depth look to KWANGDONG PHARMACEUTICAL operating, investing, and financing activities

009290 free cash flow for Q3 24 is 4.59 B KRW. For 2023, 009290 free cash flow was -46.52 B KRW and operating cash flow was -11.73 B KRW.